Looks like Botox is about to get a whole lot more socially acceptable!
The FDA has approved Botox injections to be used as a preventative against chronic migraines in adults.
They've recommended that the drug be injected every three months, around the head and neck, as a measure to dull headache symptoms in the future.
According to a statement, Botox "has not been shown to work against migraines that occur 14 days or fewer per month, nor has it been shown to work for other forms of headache."
Okay, so it doesn't work for ALL migraines, but at least it seems to be useful for seriously chronic sufferers.
Here's what associate professor of neurology at Harvard Medical School, Dr. Elizabeth W. Loder, had to say about this new usage of Botox:
"The benefits are modest when you look at the overall results. But, of course, within those results, there are always patients who do much better than the average and there are patients who don't have any benefit.
It will provide more options for patients who currently have very few forms of treatment available to them … when you are dealing with a problem like this, even modest improvement can mean the difference between being able to go to work and not being able to function very well."
Certainly an inneresting new revelation. We'll def be curious to hear more before we jump on the Botox bandwagon!
[Image via AP Images.]
Tags: botox, chronic migraines, dr elizabeth w loder, fda, harvard medical school, headache, injections, neurology, professor